According to a market report by Lucintel, the future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $17.9 billion by 2031 with a CAGR of 11.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.
A more than 150-page report to understand trends, opportunity and forecast in prenatal testing & newborn screening market to 2031 by diagnostic type (invasive and non-invasive), technology (screening technology and diagnostic technology), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)..
Lucintel forecasts that, within the diagnostic type category, non-invasive is expected to witness a higher growth over the forecast period due to its capacity to impose no risk to the fetus and lower the chance of miscarriage.
Within the end use category, hospital is expected to witness a higher growth over the forecast perioddue to growing patients preference for this facility to make informed decisions.
Download sample by clicking on prenatal testing & newborn screening market
In terms of region, North America is expected to witness the highest growth over the forecast period due to growing number of genetic disorders cases and presence of favorable reimbursement policy in the region.
Perkinelmer, Natera, Invitae, Centogene, Cradle Genomics, Hoffmann-La Roche, Quest Diagnostics, Baebies, Ravgen, Eurofins Scientific are the major suppliers in the prenatal testing & newborn screening market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056
Explore Our Latest Publications
Colorant for Synthetic Leather Market
Modified Novolac Epoxy Resin Market
VLP Ultra Low Profile Copper Foil Market
RTF Reverse Copper Foil Market
Thermal Recording Paper Market
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/prenatal-testing-and-newborn-screening-market.aspx